0 followers
MIODx® is using its custom ClonoMap platform to profile an individual’s adaptive immune system over time. The ultimate goal is to use T cell diversity as a prognostic tool to improve medical outcomes.
Industries
Headquarters
Employees
Links
M. Allen Northrup Frsc